Test Price
2,800 AED✅ Home Collection Available
SALL4 Gene Duane Retraction Syndrome Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
Advanced genetic testing for SALL4 gene mutations with 99.9% diagnostic accuracy, DHA-regulated and ISO 9001:2015 certified.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 accredited NGS processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM.
- Clinical Guidance: Complimentary post-test telephonic result interpretation by a DHA-licensed specialist.
- Insurance: Direct billing verification via WhatsApp at +971 54 548 8731.
ISO 9001:2015 Certified – Cert. INT/EGQ/2509DA/3139 | DHA Facility License: 1143
Test Overview & Methodology
The SALL4 Gene Duane Retraction Syndrome Genetic Test is a next-generation sequencing assay that screens the entire coding region of the SALL4 gene for pathogenic variants linked to Duane-radial ray syndrome (Okihiro syndrome) and isolated Duane retraction syndrome. This test is vital for confirming a clinical diagnosis, guiding familial recurrence risk, and enabling early intervention. Relevant clinical specialists include Pediatricians, Ophthalmologists, and Clinical Geneticists who interpret results in the context of full systemic evaluation.
| Feature | Our Test (NGS) | Closest Alternative (Sanger) |
|---|---|---|
| Detection Scope | Full gene sequencing + CNV analysis | Single variant or limited exon sequencing |
| Sensitivity | >99.9% for SNVs & indels | High for known hotspots only |
| Turnaround Time | 3–4 Weeks | 4–6 Weeks |
Physician Insight & Safety Protocols
"This SALL4 gene test provides valuable diagnostic information for Duane retraction syndrome, but results must always be correlated with a thorough clinical and ophthalmological examination. Genetic counseling should accompany the testing process to ensure families fully understand recurrence risks and the implications of both positive and negative findings."
— Lina Osama Zaki Quteineh, Consultant Medical Genetics | DHA Registration ID: 9294403
Safety Advisory
Do not discontinue any prescribed medications or treatments without direct consultation with your physician. Genetic test results are not substitutes for urgent medical care.
Exclusion Criteria & Safety Alerts
- Active systemic infection or recent blood transfusion (within 4 weeks) may affect DNA quality; reschedule after recovery.
- Genetic testing for minors requires explicit parental consent under UAE Federal Law No. 2 of 2019 and the Federal Decree-Law No. 45 of 2021 on Personal Data Protection.
- If the patient experiences acute vision loss, severe eye pain, or sudden strabismus changes, seek immediate emergency care—do not wait for test results.
Patient FAQ & Clinical Guidance
1. What does the SALL4 gene test detect and why is it ordered?
Answer: This NGS test identifies SALL4 gene mutations responsible for Duane retraction syndrome and Okihiro syndrome. It is ordered when a patient presents with clinical features such as limited eye movement, strabismus, or radial ray anomalies, to confirm the diagnosis and guide family counseling.
2. How is the test performed and how long do results take?
Answer: A peripheral blood sample is collected via our VIP mobile phlebotomy service or at our facility. The DNA is extracted and analyzed using next-generation sequencing. Results are typically available within 3 to 4 weeks.
3. Will insurance cover this test and what regulations apply?
Answer: We verify direct billing with major insurance providers in the UAE. The test is performed under the regulatory oversight of the Dubai Health Authority (DHA) and complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 on health information usage. All genetic data is stored on secure, compliant servers.
UAE Regulatory & Data Privacy Adherence
Data Protection & Compliance: This facility operates in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All patient genetic data is encrypted, access-controlled, and processed under strict confidentiality protocols. Clinical safety and patient consent are governed by Federal Decree-Law No. 4 of 2016 on Medical Liability. ISO 9001:2015 certified (Cert: INT/EGQ/2509DA/3139). DHA Facility License No. 1143.
Clinical & Logistical Metadata
| Test Name | SALL4 Gene Duane Retraction Syndrome Genetic Test (NGS) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood (3–5 mL in EDTA tube) |
| Methodology Used | Next-Generation Sequencing (NGS) – Full gene sequencing with CNV analysis |
| ICD-10-CM Code | H50.81 |
| LOINC Code | 83202-2 |
| DHA Facility License & Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians